Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 12/05 10:00:00 pm
82.45 USD   +0.29%
12/01 BIOMARIN PHARMA : Active Biotech Company Shares in the News
11/29 NASDAQ 100 MOVE : Bmrn, nflx
11/09 NASDAQ 100 MOVE : Trip, bmrn
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2016 11/30/2016 12/01/2016 12/02/2016 12/05/2016 Date
86.7(c) 85.63(c) 83.33(c) 82.21(c) 82.45(c) Last
1 116 323 1 471 535 1 194 580 1 142 525 1 666 663 Volume
-1.88% -1.23% -2.69% -1.34% +0.29% Change
More quotes
Financials ($)
Sales 2016 1 115 M
EBIT 2016 -755 M
Net income 2016 -579 M
Finance 2016 108 M
Yield 2016 -
Sales 2017 1 317 M
EBIT 2017 -160 M
Net income 2017 -182 M
Finance 2017 54,8 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 12,6x
EV / Sales2017 10,7x
Capitalization 14 139 M
More Financials
Company
BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.The company was founded on March 21, 1997 and... 
Sector
Pharmaceuticals
Calendar
12/08 | 02:45pmPresentation
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOMARIN PHARMACEUTICAL IN
12/02 BIOMARIN PHARMACEUTICAL INC : Entry into a Material Definitive Agreement, Creati..
12/01 BIOMARIN PHARMACEUTICAL : Active Biotech Company Shares in the News
11/29 NASDAQ 100 MOVERS : Bmrn, nflx
11/09 NASDAQ 100 MOVERS : Trip, bmrn
11/07 BIOMARIN PHARMACEUTICAL INC. : (BMRN) is Trading Higher on Unusual Volume for No..
11/03 BIOMARIN PHARMACEUTICAL : Management's Discussion and Analysis of Financial Cond..
11/03 BioMarin to Attend Three Upcoming Investor Conferences
11/02 BIOMARIN PHARMACEUTICAL : Expected for Biomarin Pharmaceutical inc.sales of $318..
10/27 BIOMARIN PHARMACEUTICAL : reports 3Q loss
10/27 BIOMARIN PHARMACEUTICAL INC : Results of Operations and Financial Condition, Fin..
More news
Sector news : Biopharmaceuticals
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Biopharmaceuticals
News from SeekingAlpha
11/29 Barclays softens views on five biopharma firms
11/25 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2016 Update
11/23 Biotech And Big Pharma Are Acting As If Hillary Clinton Won The Election
11/18 Gilead has multiple prospects if it decides to pull trigger on acquisition
11/11 Healthcare ratings roundup - downgrades
Advertisement
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Technical analysis trends BIOMARIN PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 114 $
Spread / Average Target 39%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jean-Jacques Bienaimé Chairman & Chief Executive Officer
Daniel K. Spiegelman Chief Financial Officer & Executive Vice President
Henry J. Fuchs Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux Chief Information Officer & Vice President
Elaine J. Heron Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..-20.46%14 139
BIOGEN INC-2.99%64 661
CSL LIMITED-5.78%33 156
ALEXION PHARMACEUTICAL..-35.54%27 574
GRIFOLS SA-16.87%12 072
CHONGQING ZHIFEI BIOLO..--.--%4 303
More Results